Tokushima, Japan

Satoshi Kido


Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Naruto, JP (2012)
  • Tokushima, JP (2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Satoshi Kido: Innovator in Pharmaceutical Chemistry

Introduction

Satoshi Kido is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds aimed at treating various health conditions. With a total of 2 patents to his name, Kido's work is recognized for its potential impact on medical treatments.

Latest Patents

Kido's latest patents focus on phenylimidazole compounds, which are designed to provide effective pharmaceutical products for the prevention and treatment of hyperlipidemia, obesity, and related conditions. These compounds, represented by a specific formula, include pharmaceutically acceptable salts and are part of a broader pharmaceutical composition and lipoprotein lipase activator. The objective of this research is to create a chemotherapeutic agent that can significantly improve patient outcomes.

Career Highlights

Satoshi Kido is currently employed at Otsuka Pharmaceutical Factory, Inc., where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to advancing medical science and improving health care options for patients.

Collaborations

Kido collaborates with notable colleagues, including Tadao Shibutani and Koushi Iwata, who contribute to his research efforts and help drive the development of new pharmaceutical products.

Conclusion

Satoshi Kido's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key figure in the industry. His work not only advances scientific knowledge but also holds promise for improving health outcomes for many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…